Treating androgen decline in aging male (adam)-associated conditions with sarms

A method of preventing, suppressing, inhibiting or reducing the incidence of an Androgen Decline in Aging Male (ADAM)-associated condition in a male subject, said method comprising the step of administering to said subject a selective androgen receptor modulator (SARM) compound represented by the structure of formula I:

• wherein G is O or S;
• X is O;
• T is OH, OR, —NHCOCH3, or NHCOR
• Z is NO2, CN, COOH, COR, NHCOR or CONHR;
• Y is CF3, F, I, Br, Cl, CN, C(R)3 or Sn(R)3;
• Q is alkyl, F, Cl, Br, I, CF3, CN, C(R)3, Sn(R)3, N(R)2, NHCOCH3, NHCOCF3, NHCOR, NHCONHR, NHCOOR, OCONHR, CONHR, NHCSCH3, NHCSCF3, NHCSR, NHSO2CH3, NHSO2R, OR, COR, OCOR, OSO2R, SO2R, SR, NCS, SCN, NCO, OCN;
• R is alkyl, haloalkyl, dihaloalkyl, trihaloalkyl, CH2F, CHF2, CF3, CF2CF3, aryl, phenyl, F, Cl, Br, I, alkenyl or OH;
• and
• R1 is CH3, CH2F, CHF2, CF3, CH2CH3, or CF2CF3.
• or its isomer, metabolite, pharmaceutically acceptable salt, hydrate or N-oxide, or crystal.